✦ LIBER ✦

Structure-based phenotyping predicts HIV-1 protease inhibitor resistance

✍ Scribed by Mark D. Shenderovich; Ron M. Kagan; Peter N.R. Heseltine; Kal Ramnarayan

Book ID: 111752155
Publisher: Cold Spring Harbor Laboratory Press
Year: 2003
Tongue: English
Weight: 333 KB
Volume: 12
Category: Article
ISSN: 0961-8368
DOI: 10.1110/ps.0301103

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Overcoming HIV-1 resistance to protease

Overcoming HIV-1 resistance to protease inhibitors

✍ Ernesto Freire 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 278 KB

HIV-1 protease inhibitors: effects on HI

HIV-1 protease inhibitors: effects on HIV-2 replication and resistance

✍ Luis Menéndez-Arias; József Tözsér 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 978 KB

Prediction of HIV-1 Protease/Inhibitor A

Prediction of HIV-1 Protease/Inhibitor Affinity using RosettaLigand

✍ Gordon Lemmon; Kristian Kaufmann; Jens Meiler 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 894 KB

Structure-based design of non-peptide HI

Structure-based design of non-peptide HIV protease inhibitors

✍ Arun K. Ghosh; Dongwoo Shin; Lisa Swanson; K. Krishnan; Hanna Cho; Khaja Azhar H 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 98 KB

P1′ Oxadiazole Protease Inhibitors with

P1′ Oxadiazole Protease Inhibitors with Excellent Activity Against Native and Protease Inhibitor-Resistant HIV-1.

✍ Ronald M. Kim; Elizabeth A. Rouse; Kevin T. Chapman; William A. Schleif; David B 📂 Article 📅 2004 🏛 John Wiley and Sons ⚖ 34 KB 👁 2 views

Longitudinal use of phenotypic resistanc

Longitudinal use of phenotypic resistance testing to HIV-1 protease inhibitors in patients developing HAART failure

✍ Jean Servais; Jean-Marc Plesséria; Christine Lambert; Elodie Fontaine; Isabelle 📂 Article 📅 2002 🏛 John Wiley and Sons 🌐 English ⚖ 90 KB

## Abstract An “in‐house” recombinant virus protease inhibitor susceptibility assay was carried out (median of 3 per patient) retrospectively in 26 patients failing HIV protease inhibitor based therapy at regular intervals to the initiation of the first protease inhibitor. Patients were treated wit